{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:00:40Z","timestamp":1792598440688,"version":"4.5.0"},"reference-count":107,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-023-01697-7","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T03:05:49Z","timestamp":1689735949000},"page":"2179-2190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Nephrotic syndrome: pathophysiology and consequences"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6060-965X","authenticated-orcid":false,"given":"Claudio","family":"Ponticelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"issue":"6","key":"1697_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/sj.ki.5002041","volume":"71","author":"LM Russo","year":"2007","unstructured":"Russo LM, Sandoval RM, McKee M, Osicka TM, Collins AB, Brown D, Molitoris BA, Comper WD (2007) The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 71(6):504\u2013513","journal-title":"Kidney Int"},{"issue":"1","key":"1697_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.kint.2015.11.007","volume":"89","author":"R Nielsen","year":"2016","unstructured":"Nielsen R, Christensen EI, Birn H (2016) Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int 89(1):58\u201367","journal-title":"Kidney Int"},{"issue":"4","key":"1697_CR3","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1152\/physrev.00014.2021","volume":"102","author":"BA Molitoris","year":"2022","unstructured":"Molitoris BA, Sandoval RM, Yadav SPS, Wagner MC (2022) Albumin uptake and processing by the proximal tubule: physiological, pathological, and therapeutic implications. Physiol Rev 102(4):1625\u20131667","journal-title":"Physiol Rev"},{"issue":"3","key":"1697_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2008050503","volume":"20","author":"LM Russo","year":"2009","unstructured":"Russo LM, Sandoval RM, Campos SB, Molitoris BA, Comper WD, Brown D (2009) Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J Am Soc Nephrol 20(3):489\u2013499","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1697_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/1440-1681.12878","volume":"45","author":"Y Han","year":"2018","unstructured":"Han Y, Ly NDK, Tesch GH, Poronnik P, Nikolic-Paterson DJ (2018) Reduced tubular degradation of glomerular filtered plasma albumin is a common feature in acute and chronic kidney disease. Clin Exp Pharmacol Physiol 45(3):241\u2013249","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4","key":"1697_CR6","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","volume":"63","author":"K Iseki","year":"2003","unstructured":"Iseki K, Ikemiya Y, Iseki C, Takishita S (2003) Proteinuria and the risk of developing end-stage renal disease. Kidney Int 63(4):1468\u20131474","journal-title":"Kidney Int"},{"issue":"13","key":"1697_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJM199403313301301","volume":"330","author":"S Klahr","year":"1994","unstructured":"Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330(13):877\u2013884","journal-title":"N Engl J Med"},{"issue":"5","key":"1697_CR8","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1046\/j.1523-1755.1998.00874.x","volume":"53","author":"P Ruggenenti","year":"1998","unstructured":"Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G (1998) Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. \u201cGruppo Italiano di Studi Epidemiologici in Nefrologia\u201d (GISEN). Kidney Int 53(5):1209\u20131216","journal-title":"Kidney Int"},{"issue":"4","key":"1697_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/0272-6386(95)90120-5","volume":"25","author":"JJ Rydel","year":"1995","unstructured":"Rydel JJ, Korbet SM, Borok RZ, Schwartz MM (1995) Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis 25(4):534\u2013542","journal-title":"Am J Kidney Dis"},{"key":"1697_CR10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/ki.1997.127","volume":"51","author":"DC Cattran","year":"1997","unstructured":"Cattran DC, Pei Y, Greenwood CM, Ponticelli C, Passerini P, Honkanen E (1997) Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int 51:901\u2013907","journal-title":"Kidney Int"},{"issue":"4","key":"1697_CR11","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0272-6386(99)70384-7","volume":"34","author":"C Ponticelli","year":"1999","unstructured":"Ponticelli C, Villa M, Banfi G, Cesana B, Pozzi C, Pani A, Passerini P, Farina M, Grassi C, Baroli A (1999) Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis 34(4):618\u2013625","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1697_CR12","doi-asserted-by":"publisher","first-page":"e0228337","DOI":"10.1371\/journal.pone.0228337","volume":"15","author":"A Ogawa-Akiyama","year":"2020","unstructured":"Ogawa-Akiyama A, Sugiyama H, Kitagawa M et al (2020) Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome. PLoS ONE 15(1):e0228337","journal-title":"PLoS ONE"},{"key":"1697_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106153","volume":"143","author":"YM Teh","year":"2022","unstructured":"Teh YM, Mualif SA, Lim SK (2022) A comprehensive insight into autophagy and its potential signaling pathways as a therapeutic target in podocyte injury. Int J Biochem Cell Biol 143:106153","journal-title":"Int J Biochem Cell Biol"},{"key":"1697_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfad024","author":"C Ponticelli","year":"2023","unstructured":"Ponticelli C, Moroni G, Reggiani F (2023) Autophagy and podocytopathy. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfad024. (Online ahead of print)","journal-title":"Nephrol Dial Transplant"},{"key":"1697_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1523-1755.2005.67097.x","volume":"67","author":"W Kriz","year":"2005","unstructured":"Kriz W, LeHir M (2005) Pathways to nephron loss starting from glomerular diseases-insights from animal mode. Kidney Int 67:404\u2013419","journal-title":"Kidney Int"},{"issue":"3","key":"1697_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/MNH.0000000000000596","volume":"29","author":"L Anguiano","year":"2020","unstructured":"Anguiano L, Kain R, Anders HJ (2020) The glomerular crescent: triggers, evolution, resolution, and implications for therapy. Curr Opin Nephrol Hypertens 29(3):302\u2013309","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"1697_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.semnephrol.2012.06.007","volume":"32","author":"B Smeets","year":"2012","unstructured":"Smeets B, Moeller MJ (2012) Parietal epithelial cells and podocytes in glomerular diseases. Semin Nephrol 32(4):357\u2013367","journal-title":"Semin Nephrol"},{"issue":"3","key":"1697_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrneph.2010.174","volume":"7","author":"RJ Baines","year":"2011","unstructured":"Baines RJ, Brunskill NJ (2011) Tubular toxicity of protenuria. Nat Rev Nephrol 7(3):177\u2013180","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"1697_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000516911","volume":"46","author":"S Sharma","year":"2021","unstructured":"Sharma S, Smyth B (2021) From proteinuria to fibrosis: an update on pathophysiology and treatment options. Kidney Blood Press Res 46(4):411\u2013420","journal-title":"Kidney Blood Press Res"},{"issue":"6","key":"1697_CR20","doi-asserted-by":"publisher","first-page":"F1271","DOI":"10.1152\/ajprenal.00125.2016","volume":"311","author":"AC Nolin","year":"2016","unstructured":"Nolin AC, Mulhern RM, Panchenko MV, Pisarek-Horowitz A, Wang Z, Shirihai O, Borkan SC, Havasi A (2016) Proteinuria causes dysfunctional autophagy in the proximal tubule. Am J Physiol Renal Physiol 311(6):F1271\u2013F1279","journal-title":"Am J Physiol Renal Physiol"},{"key":"1697_CR21","doi-asserted-by":"publisher","first-page":"F1297","DOI":"10.1152\/ajprenal.90761.2008","volume":"296","author":"HJ Kim","year":"2009","unstructured":"Kim HJ, Moradi H, Yuan J, Norris K, Vaziri ND (2009) Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol 296:F1297-1306","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"1697_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ki.1986.36","volume":"29","author":"GA Kaysen","year":"1986","unstructured":"Kaysen GA, Gambertoglio J, Jimenez I, Jones H, Hutchison FN (1986) Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int 29(2):572\u2013577","journal-title":"Kidney Int"},{"issue":"6","key":"1697_CR23","doi-asserted-by":"publisher","first-page":"25145","DOI":"10.1038\/srep25145","volume":"28","author":"A Pezeshki","year":"2016","unstructured":"Pezeshki A, Zapata RC, Singh A, Yee NJ, Chelikani PK (2016) Low protein diets produce divergent effects on energy balance. Sci Rep 28(6):25145","journal-title":"Sci Rep"},{"issue":"1","key":"1697_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11906-014-0511-3","volume":"17","author":"SG Chrysant","year":"2015","unstructured":"Chrysant SG, Chrysant GS (2015) Dual renin-angiotensin-aldosterone blockade: promises and pitfalls. Curr Hypertens Rep 17(1):511","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"1697_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000513119","volume":"145","author":"M Mei","year":"2021","unstructured":"Mei M, Zhou Z, Zhang Q, Chen Y, Zhao H, Shen B (2021) Dual blockade of the renin-angiotensin system: a strategy that should be reconsidered in cardiorenal diseases? Nephron 145(2):99\u2013106","journal-title":"Nephron"},{"issue":"6","key":"1697_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000517020","volume":"52","author":"H Trujillo","year":"2021","unstructured":"Trujillo H, Caravaca-Font\u00e1n F, Caro J, Morales E, Praga M (2021) The forgotten antiproteinuric properties of diuretics. Am J Nephrol 52(6):435\u2013449","journal-title":"Am J Nephrol"},{"issue":"6","key":"1697_CR27","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/ki.2015.249","volume":"88","author":"E Morales","year":"2015","unstructured":"Morales E, Caro J, Gutierrez E, Sevillano A, Au\u00f1\u00f3n P, Fernandez C et al (2015) Diverse diuretics regimens differentially enhance the antialbuminuric effect of renin-angiotensin blockers in patients with chronic kidney disease. Kidney Int 88(6):1434\u20131441","journal-title":"Kidney Int"},{"issue":"1","key":"1697_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12882-016-0337-0","volume":"17","author":"G Currie","year":"2016","unstructured":"Currie G, Taylor AH, Fujita T, Ohtsu H, Lindhardt M, Rossing P, Boesby L, Edwards NC, Ferro CJ, Townend JN, van den Meiracker AH, Saklayen MG, Oveisi S, Jardine AG, Delles C, Preiss DJ, Mark PB (2016) Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol 17(1):127","journal-title":"BMC Nephrol"},{"issue":"4","key":"1697_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1254\/jphs.08R02CR","volume":"108","author":"H Kiyomoto","year":"2008","unstructured":"Kiyomoto H, Rafiq K, Mostofa M, Nishiyama A (2008) Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury. J Pharmacol Sci 108(4):399\u2013405","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"1697_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2337\/db15-0473","volume":"65","author":"A Tagawa","year":"2016","unstructured":"Tagawa A, Yasuda M, Kume S, Yamahara K, Nakazawa J, Chin-Kanasaki M, Araki H, Araki S, Koya D, Asanuma K, Kim EH, Haneda M, Kajiwara N, Hayashi K, Ohashi H, Ugi S, Maegawa H, Uzu T (2016) Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy. Diabetes 65(3):755\u2013767","journal-title":"Diabetes"},{"issue":"10","key":"1697_CR31","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","volume":"134","author":"HJL Heerspink","year":"2016","unstructured":"Heerspink HJL, Perkins BA, David H, Fitchett DH, Husain M, David ZI, Cherney DZ (2016) Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications. Circulation 134(10):752\u2013772","journal-title":"Circulation"},{"key":"1697_CR32","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","volume":"68","author":"R Agarwal","year":"2005","unstructured":"Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, Williams L, Batlle D (2005) Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int 68:2823\u20132828","journal-title":"Kidney Int"},{"issue":"3","key":"1697_CR33","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1046\/j.1523-1755.2002.00520.x","volume":"62","author":"HF Cheng","year":"2002","unstructured":"Cheng HF, Wang CJ, Moeckel GW, Zhang MZ, McKanna JA et al (2002) Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension. Kidney Int 62(3):929\u2013939","journal-title":"Kidney Int"},{"key":"1697_CR34","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2215\/CJN.14331218","volume":"14","author":"M Bakhriansyah","year":"2019","unstructured":"Bakhriansyah M, Souverein PC, van den Hoogen MWF, de Boer A, Klungel OH (2019) Risk of nephrotic syndrome for non-steroidal anti-inflammatory drug users: a case-control study. Clin J Am Soc Nephrol 14:1355\u20131362","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"1697_CR35","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P (2008) The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14(9):931\u2013938","journal-title":"Nat Med"},{"issue":"11","key":"1697_CR36","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1681\/ASN.2015080896","volume":"27","author":"H Yu","year":"2016","unstructured":"Yu H, Kistler A, Faridi MH, Meyer JO, Tryniszewska B, Mehta D, Yue L, Dryer S, Reiser J (2016) Synaptopodin limits TRPC6 podocyte surface expression and attenuates proteinuria. J Am Soc Nephrol 27(11):3308\u20133319","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1697_CR37","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.kint.2022.02.040","volume":"102","author":"S Drovandi","year":"2022","unstructured":"Drovandi S, Lipska-Zi\u0119tkiewicz BS, Ozaltin F, Emma F, Gulhan B, Boyer O, Trautmann A, Xu H, Shen Q, Rao J, Riedhammer KM, Heemann U, Hoefele J, Stenton SL, Tsygin AN, Ng KH, Fomina S, Benetti E, Aurelle M, Prikhodina L, Schreuder MF, Tabatabaeifar M, Jankowski M, Baiko S, Mao J, Feng C, Liu C, Sun S, Deng F, Wang X, Clav\u00e9 S, Sta\u0144czyk M, Ba\u0142asz-Chmielewska I, Fila M, Durkan AM, Levart TK, Dursun I, Esfandiar N, Haas D, Bjerre A, Anarat A, Benz MR, Talebi S, Hooman N, Ariceta G, PodoNet Consortium; mitoNET Consortium; CCGKDD Consortium, Schaefer F (2022) Variation of the clinical spectrum and genotype-phenotype associations in Coenzyme Q10 deficiency associated glomerulopathy. Kidney Int 102(3):592\u2013603","journal-title":"Kidney Int"},{"issue":"5","key":"1697_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000168644","volume":"13","author":"GA Kaysen","year":"1993","unstructured":"Kaysen GA (1993) The nephrotic syndrome: pathogenesis and consequences. The homeostatic and pathogenic consequences of proteinuria. Introduction. Am J Nephrol 13(5):309\u2013310","journal-title":"Am J Nephrol"},{"issue":"12","key":"1697_CR39","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1093\/ndt\/17.12.2220","volume":"17","author":"GK Dogra","year":"2002","unstructured":"Dogra GK, Herrmann S, Irish AB, Thomas MA, Watts GF (2002) Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant 17(12):2220\u20132225","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1697_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","volume":"43","author":"PB Soeters","year":"2019","unstructured":"Soeters PB, Wolfe RR, Shenkin A (2019) Hypoalbuminemia: pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr 43(2):181\u2013193","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"6","key":"1697_CR41","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/ndt\/gfx229","volume":"33","author":"J Lang","year":"2018","unstructured":"Lang J, Katz R, Ix JH, Gutierrez OM, Peralta CA, Parikh CR, Satterfield S, Petrovic S, Devarajan P, Bennett M, Fried LF, Cummings SR, Sarnak MJ, Shlipak MG (2018) Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders. Nephrol Dial Transplant 33(6):986\u2013992","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1697_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10157-016-1251-2","volume":"21","author":"H Kikuchi","year":"2017","unstructured":"Kikuchi H, Kanda E, Mandai S, Akazawa M, Iimori S, Oi K, Naito S, Noda Y, Toda T, Tamura T, Sasaki S, Sohara E, Okado T, Rai T, Uchida S (2017) Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study. Clin Exp Nephrol 21(1):55\u201362","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"1697_CR43","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/ndt\/gfx331","volume":"33","author":"CP Walther","year":"2018","unstructured":"Walther CP, Guti\u00e9rrez OM, Cushman M, Judd SE, Lang J, McClellan W, Muntner P, Sarnak MJ, Shlipak MG, Warnock DG, Katz R, Ix JH (2018) Serum albumin concentration and risk of end-stage renal disease: the REGARDS study. Nephrol Dial Transplant 33(10):1770\u20131777","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"1697_CR44","first-page":"109","volume":"37","author":"A Yoshimura","year":"1992","unstructured":"Yoshimura A, Ideura T, Iwasaki S, Taira T, Koshikawa S (1992) Aggravation of minimal change nephrotic syndrome by administration of human albumin. Clin Nephrol 37(3):109\u2013114","journal-title":"Clin Nephrol"},{"issue":"12","key":"1697_CR45","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3390\/medicina58121780","volume":"58","author":"G Klinkmann","year":"2022","unstructured":"Klinkmann G, Klammt S, J\u00e4schke M, Henschel J, Gloger M, Reuter DA, Mitzner S (2022) Impact of albumin binding function on pharmacokinetics and pharmacodynamics of furosemide. Medicina (Kaunas) 58(12):1780","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"1697_CR46","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00467-013-2435-6","volume":"28","author":"D Bockenhauer","year":"2013","unstructured":"Bockenhauer D (2013) Over- or underfill: not all nephrotic states are created equal. Pediatr Nephrol 28(8):1153\u20131156","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"1697_CR47","doi-asserted-by":"publisher","first-page":"F575","DOI":"10.1152\/ajprenal.00229.2015","volume":"309","author":"CW Teoh","year":"2015","unstructured":"Teoh CW, Robinson LA, Noone D (2015) Perspectives on edema in childhood nephrotic syndrome. Am J Physiol Renal Physiol 309(7):F575-582","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"1697_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/MNH.0000000000000578","volume":"29","author":"GR Hinrichs","year":"2020","unstructured":"Hinrichs GR, Jensen BL, Svenningsen P (2020) Mechanisms of sodium retention in nephrotic syndrome. Curr Opin Nephrol Hypertens 29(2):207\u2013212","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"10","key":"1697_CR49","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1111\/jcmm.14387","volume":"23","author":"A Larionov","year":"2019","unstructured":"Larionov A, Dahlke E, Kunke M, Zanon Rodriguez L, Schiessl IM, Magnin JL, Kern U, Alli AA, Mollet G, Schilling O, Castrop H, Theilig F (2019) Cathepsin B increases ENaC activity leading to hypertension early in nephrotic syndrome. J Cell Mol Med 23(10):6543\u20136553","journal-title":"J Cell Mol Med"},{"issue":"6","key":"1697_CR50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ki.2012.180","volume":"82","author":"EC Siddall","year":"2012","unstructured":"Siddall EC, Radhakrishnan J (2012) The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int 82(6):635\u2013642","journal-title":"Kidney Int"},{"issue":"2","key":"1697_CR51","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.ajkd.2021.09.029","volume":"80","author":"JE Novak","year":"2022","unstructured":"Novak JE, Ellison DH (2022) Diuretics in states of volume overload: core curriculum 2022. Am J Kidney Dis 80(2):264\u2013276","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"1697_CR52","doi-asserted-by":"publisher","first-page":"e0260312","DOI":"10.1371\/journal.pone.0260312","volume":"16","author":"TH Lee","year":"2021","unstructured":"Lee TH, Kuo G, Chang CH, Huang YT, Yen CL, Lee CC, Fan PC, Chen JJ (2021) Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: an updated systematic review and meta-analysis. PLoS ONE 16(12):e0260312","journal-title":"PLoS ONE"},{"issue":"8","key":"1697_CR53","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00467-021-05358-4","volume":"37","author":"E Hedin","year":"2022","unstructured":"Hedin E, Bijeli\u0107 V, Barrowman N, Geier P (2022) Furosemide and albumin for the treatment of nephrotic edema: a systematic review. Pediatr Nephrol 37(8):1747\u20131757","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"1697_CR54","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s11255-019-02180-8","volume":"51","author":"T Masuda","year":"2019","unstructured":"Masuda T, Ohara K, Nagayama I, Matsuoka R, Murakami T, Nakagawa S, Oka K, Asakura M, Igarashi Y, Fukaya Y, Miyazawa Y, Maeshima A, Akimoto T, Saito O, Nagata D (2019) Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patients. Int Urol Nephrol 51(9):1623\u20131629","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1697_CR55","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nrneph.2017.175","volume":"14","author":"S Agrawal","year":"2017","unstructured":"Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE (2017) Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol 14(1):70","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1697_CR56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","volume":"90","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND (2016) Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int 90(1):41\u201352","journal-title":"Kidney Int"},{"issue":"4","key":"1697_CR57","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jacl.2018.05.002","volume":"12","author":"R Ishibashi","year":"2018","unstructured":"Ishibashi R, Takemoto M, Tsurutani Y, Kuroda M, Ogawa M, Wakabayashi H, Uesugi N, Nagata M, Imai N, Hattori A, Sakamoto K, Kitamoto T, Maezawa Y, Narita I, Hiroi S, Furuta A, Miida T, Yokote K (2018) Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: a case report and literature review. J Clin Lipidol 12(4):888-897.e2","journal-title":"J Clin Lipidol"},{"issue":"1","key":"1697_CR58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.115.020912","volume":"134","author":"ME Haas","year":"2016","unstructured":"Haas ME, Levenson AE, Sun X, Liao WH, Rutkowski JM, de Ferranti SD, Schumacher VA, Scherer PE, Salant DJ, Biddinger SB (2016) The role of proprotein convertase subtilisin\/kexin type 9 in nephrotic syndrome-associated hypercholesterolemia. Circulation 134(1):61\u201372","journal-title":"Circulation"},{"key":"1697_CR59","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nrneph.2016.111","volume":"12","author":"AWJ Morris","year":"2016","unstructured":"Morris AWJ (2016) PCSK9: a target for hypercholesterolaemia in nephrotic syndrome. Nat Rev Nephrol 12:510","journal-title":"Nat Rev Nephrol"},{"key":"1697_CR60","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40620-016-0278-5","volume":"29","author":"A Izquierdo-Lahuerta","year":"2016","unstructured":"Izquierdo-Lahuerta A, Mart\u00ednez-Garc\u00eda C, Medina-G\u00f3mez G (2016) Lipotoxicity as a trigger factor of renal disease. J Nephrol 29:603\u2013610","journal-title":"J Nephrol"},{"key":"1697_CR61","doi-asserted-by":"publisher","first-page":"F433","DOI":"10.1152\/ajprenal.00375.2015","volume":"310","author":"P Wahl","year":"2016","unstructured":"Wahl P, Ducasa GM, Fornoni A (2016) Systemic and renal lipids in kidney disease development and progression. Am J Physiol Ren Physiol 310:F433\u2013F445","journal-title":"Am J Physiol Ren Physiol"},{"issue":"6","key":"1697_CR62","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.cmet.2020.11.002","volume":"32","author":"A Fornoni","year":"2020","unstructured":"Fornoni A, Merscher S (2020) Lipid metabolism gets in a JAML during kidney disease. Cell Metab 32(6):903\u2013905","journal-title":"Cell Metab"},{"issue":"8A","key":"1697_CR63","doi-asserted-by":"publisher","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","volume":"97","author":"M Law","year":"2006","unstructured":"Law M, Rudnicka AR (2006) Statin safety: a systematic review. Am J Cardiol 97(8A):52C-60C","journal-title":"Am J Cardiol"},{"issue":"10349","key":"1697_CR64","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0140-6736(22)00916-3","volume":"400","author":"BK Kim","year":"2022","unstructured":"Kim BK, Hong SJ, Lee YJ, Hong SJ, Yun KH, Hong BK, Heo JH, Rha SW, Cho YH, Lee SJ, Ahn CM, Kim JS, Ko YG, Choi D, Jang Y, Hong MK, RACING investigators (2022) Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial. Lancet 400(10349):380\u2013390","journal-title":"Lancet"},{"issue":"12","key":"1697_CR65","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1681\/ASN.2014111097","volume":"26","author":"BA Kerlin","year":"2015","unstructured":"Kerlin BA, Waller AP, Sharma R, Chanley MA, Nieman MT, Smoyer WE (2015) Disease severity correlates with thrombotic capacity in experimental nephrotic syndrome. J Am Soc Nephrol 26(12):3009\u20133019","journal-title":"J Am Soc Nephrol"},{"key":"1697_CR66","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.thromres.2021.02.007","volume":"201","author":"AP Waller","year":"2021","unstructured":"Waller AP, Troost JP, Parikh SV, Wolfgang KJ, Rovin BH, Nieman MT, Smoyer WE, Kretzler M, Kerlin BA, NEPTUNE Investigators (2021) Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy. Thromb Res 201:50\u201359","journal-title":"Thromb Res"},{"issue":"2","key":"1697_CR67","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2215\/CJN.0000000000000047","volume":"18","author":"E Abdelghani","year":"2023","unstructured":"Abdelghani E, Waller AP, Wolfgang KJ, Stanek JR, Parikh SV, Rovin BH, Smoyer WE, Kerlin BA, PNRC Investigators, NEPTUNE Investigators (2023) Exploring the role of antithrombin in nephrotic syndrome-associated hypercoagulopathy: a multi-cohort study and meta-analysis. Clin J Am Soc Nephrol 18(2):234\u2013244","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1697_CR68","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2174\/157016111203140518172048","volume":"12","author":"A Gigante","year":"2014","unstructured":"Gigante A, Barbano B, Sardo L, Martina P, Gasperini ML, Labbadia R, Liberatori M, Amoroso A, Cianci R (2014) Hypercoagulability and nephrotic syndrome. Curr Vasc Pharmacol 12(3):512\u2013517","journal-title":"Curr Vasc Pharmacol"},{"issue":"6","key":"1697_CR69","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3324\/haematol.2021.279770","volume":"107","author":"L Li","year":"2022","unstructured":"Li L, Zhou J, Wang S, Jiang L, Chen X, Zhou Y, Li J, Shi J, Liu P, Shu Z, Gonzalez FJ, Liu A, Hu H (2022) Critical role of peroxisome proliferator-activated receptor \u03b1 in promoting platelet hyperreactivity and thrombosis under hyperlipidemia. Haematologica 107(6):1358\u20131373","journal-title":"Haematologica"},{"issue":"1","key":"1697_CR70","doi-asserted-by":"publisher","first-page":"21407","DOI":"10.1038\/s41598-020-78522-9","volume":"10","author":"JP van Geffen","year":"2020","unstructured":"van Geffen JP, Swieringa F, van Kuijk K, Tullemans BME, Solari FA, Peng B, Clemetson KJ, Farndale RW, Dubois LJ, Sickmann A, Zahedi RP, Ahrends R, Biessen EAL, Sluimer JC, Heemskerk JWM, Kuijpers MJE (2020) Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome. Sci Rep 10(1):21407","journal-title":"Sci Rep"},{"issue":"3","key":"1697_CR71","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/CH-131705","volume":"57","author":"C Irace","year":"2014","unstructured":"Irace C, Carallo C, Scavelli F, Esposito T, De Franceschi MS, Tripolino C, Gnasso A (2014) nfluence of blood lipids on plasma and blood viscosity. Clin Hemorheol Microcirc 57(3):267\u2013274","journal-title":"Clin Hemorheol Microcirc"},{"issue":"3","key":"1697_CR72","doi-asserted-by":"publisher","first-page":"F235","DOI":"10.1152\/ajprenal.00138.2015","volume":"309","author":"M St\u00e6hr","year":"2015","unstructured":"St\u00e6hr M, Buhl KB, Andersen RF, Svenningsen P, Nielsen F, Hinrichs GR, Bistrup C, Jensen BL (2015) Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine. Am J Physiol Renal Physiol 309(3):F235-241","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1697_CR73","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/00005344-200206000-00003","volume":"39","author":"JL Mehta","year":"2002","unstructured":"Mehta JL, Li DY, Yang H, Raizada MK (2002) Angiotensin II and IV stimulate expression and release of plasminogen activator inhibitor-1 in cultured human coronary artery endothelial cells. J Cardiovasc Pharmacol 39(6):789\u2013794","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"1697_CR74","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","volume":"117","author":"BK Mahmoodi","year":"2008","unstructured":"Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der Meer J (2008) High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 117(2):224\u2013230","journal-title":"Circulation"},{"issue":"3","key":"1697_CR75","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2215\/CJN.10131011","volume":"7","author":"BA Kerlin","year":"2012","unstructured":"Kerlin BA, Ayoob R, Smoyer WE (2012) Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol 7(3):513\u2013520","journal-title":"Clin J Am Soc Nephrol"},{"key":"1697_CR76","doi-asserted-by":"crossref","unstructured":"Suri D, Ahluwalia J, Saxena AK, Sodhi KS, Singh P, Mittal BR, Das R, Rawat A, Singh S (2014) Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clin Exp Nephrol 18(5):803\u2013813","DOI":"10.1007\/s10157-013-0917-2"},{"issue":"10","key":"1697_CR77","volume":"14","author":"D Casey","year":"2022","unstructured":"Casey D, Romero K, Patel R, Ouellette T, Anasseri S, Eftekhari P (2022) Bilateral renal vein thrombosis in membranous nephropathy: hypoalbuminemia predictive of venous thromboembolism in nephrotic syndrome. Cureus 14(10):e30032","journal-title":"Cureus"},{"issue":"2","key":"1697_CR78","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/ki.2011.312","volume":"81","author":"SJ Barbour","year":"2012","unstructured":"Barbour SJ, Greenwald A, Djurdjev O, Levin A, Hladunewich MA, Nachman PH, Hogan SL, Cattran DC, Reich HN (2012) Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int 81(2):190\u2013195","journal-title":"Kidney Int"},{"issue":"1","key":"1697_CR79","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10157-016-1235-2","volume":"21","author":"Y Kimura","year":"2017","unstructured":"Kimura Y, Miura N, Debiec H, Morita H, Yamada H, Banno S, Ronco P, Imai H (2017) Circulating antibodies to \u03b1-enolase and phospholipase A2 receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy. Clin Exp Nephrol 21(1):117\u2013126","journal-title":"Clin Exp Nephrol"},{"key":"1697_CR80","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/156795","volume":"2012","author":"A D\u00edaz-Ramos","year":"2012","unstructured":"D\u00edaz-Ramos A, Roig-Borrellas A, Garc\u00eda-Melero A, L\u00f3pez-Alemany R (2012) \u03b1-Enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol 2012:156795","journal-title":"J Biomed Biotechnol"},{"issue":"9","key":"1697_CR81","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1681\/ASN.2020111583","volume":"32","author":"AS Go","year":"2021","unstructured":"Go AS, Tan TC, Chertow GM, Ordonez JD, Fan D, Law D, Yankulin L, Wojcicki JM, Zheng S, Chen KK, Khoshniat-Rad F, Yang J, Parikh RV (2021) Primary nephrotic syndrome and risks of ESKD, cardiovascular events, and death: the kaiser permanente nephrotic syndrome study. J Am Soc Nephrol 32(9):2303\u20132314","journal-title":"J Am Soc Nephrol"},{"key":"1697_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-023-03467-7","author":"X Lai","year":"2023","unstructured":"Lai X, Cui Z, Zhang H, Zhang YM, Wang F, Wang X, Meng LQ, Cheng XY, Liu G, Zhao MH (2023) Long-term visit-to-visit variability in low-density lipoprotein cholesterol is associated with poor cardiovascular and kidney outcomes in patients with primary nephrotic syndrome. Int Urol Nephrol. https:\/\/doi.org\/10.1007\/s11255-023-03467-7. (Online ahead of print. PMID: 36648742)","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"1697_CR83","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00467-019-04301-y","volume":"35","author":"P Hari","year":"2020","unstructured":"Hari P, Khandelwal P, Smoyer WE (2020) Dyslipidemia and cardiovascular health in childhood nephrotic syndrome. Pediatr Nephrol 35(9):1601\u20131619","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"1697_CR84","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00467-019-04434-0","volume":"35","author":"C Alves","year":"2020","unstructured":"Alves C, Pinho JF, Dos Santos LM, Magalh\u00e3es G, da Silva JM, Fontes FL, Caligiorne SM, Pinheiro S, Rodrigues-Machado MG (2020) Augmentation index, a predictor of cardiovascular events, is increased in children and adolescents with primary nephrotic syndrome. Pediatr Nephrol 35(5):815\u2013827","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"1697_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207064","volume":"13","author":"A G\u00f6\u00e7ero\u011flu","year":"2018","unstructured":"G\u00f6\u00e7ero\u011flu A, Grenmyr E, Berden AE, Hagen EC, Bunch D, Sommarin Y, Bruijn JA, Bajema IM, Wieslander J (2018) Anti-plasminogen antibodies in ANCA-associated vasculitis: an optimized anti-plasminogen assay. PLoS ONE 13(11):e0207064","journal-title":"PLoS ONE"},{"issue":"1","key":"1697_CR86","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000448628","volume":"135","author":"AJ Rankin","year":"2017","unstructured":"Rankin AJ, McQuarrie EP, Fox JG, Geddes CC, MacKinnon B, Scottish Renal Biopsy Registry (2017) Venous thromboembolism in primary nephrotic syndrome\u2014is the risk high enough to justify prophylactic anticoagulation? Nephron 135(1):39\u201345","journal-title":"Nephron"},{"issue":"2","key":"1697_CR87","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/ki.1994.75","volume":"45","author":"FP Sarasin","year":"1994","unstructured":"Sarasin FP, Schifferli JA (1994) Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy. Kidney Int 45(2):578\u2013585","journal-title":"Kidney Int"},{"issue":"6","key":"1697_CR88","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/ki.2013.476","volume":"85","author":"T Lee","year":"2014","unstructured":"Lee T, Biddle AK, Lionaki S, Derebail VK, Barbour SJ, Tannous S, Hladunewich MA, Hu Y, Poulton CJ, Mahoney SL, Charles Jennette J, Hogan SL, Falk RJ, Cattran DC, Reich HN, Nachman PH (2014) Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. Kidney Int 85(6):1412\u20131420","journal-title":"Kidney Int"},{"issue":"4","key":"1697_CR89","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, Jayne DRW, Jha V, Liew A, Liu ZH, Mej\u00eda-Vilet JM, Nester CM, Radhakrishnan J, Rave EM, Reich HN, Ronco P, Sanders JF, Sethi S, Suzuki Y, Tang SCW, Tesar V, Vivarelli M, Wetzels JFM, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli MA, Cheung M, Earley A, Floege J (2021) Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int 100(4):753\u2013779","journal-title":"Kidney Int"},{"issue":"1","key":"1697_CR90","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12882-022-02929-x","volume":"23","author":"S Kelddal","year":"2022","unstructured":"Kelddal S, Hvas AM, Grove EL, Birn H (2022) Safety and effectiveness of direct oral anticoagulants in patients with nephrotic syndrome: a report of 21 cases. BMC Nephrol 23(1):305","journal-title":"BMC Nephrol"},{"key":"1697_CR91","doi-asserted-by":"crossref","unstructured":"Tijani A, Coons EM, Mizuki B, Dermady M, Stanilova K, Casey AL, Alqudsi M, Gastanaduy M, Elmayan A, Bamnolker A, Velez JCQ (2022) Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in patients with nephrotic syndrome: a retrospective cohort study. Ann Pharmacother, 10600280221129348","DOI":"10.1177\/10600280221129348"},{"key":"1697_CR92","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1053\/j.ajkd.2012.12.025","volume":"61","author":"DS Gipson","year":"2013","unstructured":"Gipson DS, Messer KL, Tran CL, Herreshoff EG, Samuel JP, Massengill SF et al (2013) Inpatient health care utilization in the United States among children, adolescents, and young adults with nephrotic syndrome. Am J Kidney Dis 61:910\u2013917","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1697_CR93","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00467-018-4072-6","volume":"34","author":"SL Carpenter","year":"2019","unstructured":"Carpenter SL, Goldman J, Sherman AK, Selewski DT, Kallash M, Tran CL, Seamon M, Katsoufis C, Ashoor I, Hernandez J, Supe-Markovina K, D\u2019alessandri-Silva C, DeJesus-Gonzalez N, Vasylyeva TL, Formeck C, Woll C, Gbadegesin R, Geier P, Devarajan P, Smoyer WE, Kerlin BA, Rheault MN (2019) Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome. Pediatr Nephrol 34(2):261\u2013267","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"1697_CR94","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/INF.0000000000001747","volume":"37","author":"U Narain","year":"2018","unstructured":"Narain U, Gupta A (2018) Urinary tract infection in children with nephrotic syndrome. Pediatr Infect Dis J 37(2):144\u2013146","journal-title":"Pediatr Infect Dis J"},{"key":"1697_CR95","doi-asserted-by":"publisher","first-page":"10371","DOI":"10.1016\/j.micpath.2019.103718","volume":"137","author":"H Sorkhi","year":"2019","unstructured":"Sorkhi H, Riahi SM, Ebrahimpour S, Shaikh N, Rostami A (2019) Urinary tract infection in children with nephrotic syndrome: a systematic review and meta-analysis. Microb Pathog 137:10371","journal-title":"Microb Pathog"},{"issue":"2","key":"1697_CR96","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.19082\/3728","volume":"9","author":"GM El Mashad","year":"2017","unstructured":"El Mashad GM, El Hady Ibrahim SA, Abdelnaby SAA (2017) Immunoglobulin G and M levels in childhood nephrotic syndrome: two centers Egyptian study. Electron Physician 9(2):3728\u20133732","journal-title":"Electron Physician"},{"key":"1697_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2020.103981","volume":"230","author":"M Worm","year":"2021","unstructured":"Worm M, Bohnert BN, Alenazi F, Boldt K, Klose F, Junger K, Ueffing M, Birkenfeld AL, Kalbacher H, Artunc F (2021) Proteasuria in nephrotic syndrome-quantification and proteomic profiling. J Proteomics 230:103981","journal-title":"J Proteomics"},{"issue":"4","key":"1697_CR98","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1590\/2175-8239-jbn-2019-0001","volume":"41","author":"M Kumar","year":"2019","unstructured":"Kumar M, Ghunawat J, Saikia D, Manchanda V (2019) Incidence and risk factors for major infections in hospitalized children with nephrotic syndrome. Kumar J Bras Nefrol 41(4):526\u2013533","journal-title":"Kumar J Bras Nefrol"},{"issue":"2","key":"1697_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089270","volume":"9","author":"L Vanoaica","year":"2014","unstructured":"Vanoaica L, Richman L, Jaworski M, Darshan D, Luther SA, K\u00fchn LC (2014) Conditional deletion of ferritin H in mice reduces B and T lymphocyte populations. PLoS ONE 9(2):e89270","journal-title":"PLoS ONE"},{"issue":"6","key":"1697_CR100","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s40620-019-00602-5","volume":"32","author":"C Ponticelli","year":"2019","unstructured":"Ponticelli C, Glassock RJ (2019) Prevention of complications from use of conventional immunosuppressants: a critical review. J Nephrol 32(6):851\u2013870","journal-title":"J Nephrol"},{"issue":"3","key":"1697_CR101","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s13730-021-00587-w","volume":"10","author":"T Enya","year":"2021","unstructured":"Enya T, Morimoto Y, Oshima R, Miyazaki K, Miyazawa T, Okada M, Sugimoto K (2021) Nephrotic syndrome relapse in a boy with COVID-19. CEN Case Rep 10(3):431\u2013434","journal-title":"CEN Case Rep"},{"issue":"1","key":"1697_CR102","doi-asserted-by":"publisher","DOI":"10.1111\/ped.14862","volume":"64","author":"Y Watanabe","year":"2022","unstructured":"Watanabe Y, Watanabe T, Ikeda H (2022) Case of recurrent refractory nephrotic syndrome in a Japanese boy with COVID-19. Pediatr Int 64(1):e14862","journal-title":"Pediatr Int"},{"issue":"4","key":"1697_CR103","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00467-021-05330-2","volume":"37","author":"W Morello","year":"2022","unstructured":"Morello W, Vianello FA, Proverbio E, Peruzzi L, Pasini A, Montini G (2022) COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area. Pediatr Nephrol 37(4):757\u2013764","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"1697_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.619548","volume":"5","author":"CL Tran","year":"2021","unstructured":"Tran CL, Selewski DT, Oh GJ, Troost JP, Massengill SF, Al-Akash SI, Mahesh S, Amin R, Ashoor IF, Chanchlani R, Kallash M, Woroniecki RP, Gipson DS (2021) Pediatric immunization practices in nephrotic syndrome: an assessment of provider and parental knowledge. Front Pediatr 5(8):619548","journal-title":"Front Pediatr"},{"issue":"9","key":"1697_CR105","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s10157-022-02231-y","volume":"26","author":"N Nakagawa","year":"2022","unstructured":"Nakagawa N, Maruyama S, Kashihara N, Narita I, Isaka Y (2022) New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan. Clin Exp Nephrol 26(9):909\u2013916","journal-title":"Clin Exp Nephrol"},{"issue":"30","key":"1697_CR106","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e218","volume":"36","author":"JH Lim","year":"2021","unstructured":"Lim JH, Han MH, Kim YJ, Kim MS, Jung HY, Choi JY, Cho JH, Kim CD, Kim YL, Park SH (2021) J New-onset nephrotic syndrome after Janssen COVID-19 vaccination: a case report and literature review. Korean Med Sci 36(30):e218","journal-title":"Korean Med Sci"},{"issue":"10","key":"1697_CR107","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.2215\/CJN.06400420","volume":"15","author":"A Angeletti","year":"2020","unstructured":"Angeletti A, Drovandi S, Sanguineri F, Santaniello M, Ferrando G, Forno R, Cipresso G, Caridi G, Riella LV, Cravedi P, Ghiggeri GM (2020) COVID-19 in children with nephrotic syndrome on anti-CD20 chronic immunosuppression. Clin J Am Soc Nephrol 15(10):1494\u20131495","journal-title":"Clin J Am Soc Nephrol"}],"updated-by":[{"DOI":"10.1007\/s40620-025-02400-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000}}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01697-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-023-01697-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01697-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:07Z","timestamp":1777564387000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/36\/8\/2179\/8304756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":107,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1007\/s40620-023-01697-7","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40620-025-02400-8","URL":"https:\/\/doi.org\/10.1007\/s40620-025-02400-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors have no relevant financial or non-financial interests to disclose.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Human and animal rights are respected","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"No informed consent is needed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}